Safety, Tolerability and Pharmacokinetics of Single Dose of PB-119 in Healthy Volunteers
Phase of Trial: Phase I
Latest Information Update: 16 Feb 2017
At a glance
- Drugs Exenatide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions
- Sponsors PegBio
- 13 Feb 2017 Status changed from active, no longer recruiting to completed.
- 09 Jun 2015 Status changed from recruiting to active, no longer recruiting as results presented at the 75th Annual Scientific Sessions of the American Diabetes Association
- 09 Jun 2015 Results presented at the 75th Annual Scientific Sessions of the American Diabetes Association.